Follow
John R Lozada
Title
Cited by
Cited by
Year
Recurrent hotspot mutations in HRAS Q61 and PI3K-AKT pathway genes as drivers of breast adenomyoepitheliomas
FC Geyer, A Li, AD Papanastasiou, A Smith, P Selenica, KA Burke, ...
Nature communications 9 (1), 1816, 2018
1322018
Loss-of-function mutations in ATP6AP1 and ATP6AP2 in granular cell tumors
F Pareja, AH Brandes, T Basili, P Selenica, FC Geyer, D Fan, ...
Nature Communications 9 (1), 3533, 2018
1082018
Solid papillary breast carcinomas resembling the tall cell variant of papillary thyroid neoplasms (solid papillary carcinomas with reverse polarity) harbour recurrent mutations …
JR Lozada, T Basili, F Pareja, B Alemar, ADC Paula, R Gularte‐Merida, ...
Histopathology 73 (2), 339-344, 2018
572018
Homologous recombination DNA repair defects in PALB2-associated breast cancers
A Li, FC Geyer, P Blecua, JY Lee, P Selenica, DN Brown, F Pareja, ...
NPJ breast cancer 5 (1), 23, 2019
532019
Histologic classification and molecular signature of polymorphous adenocarcinoma (PAC) and cribriform adenocarcinoma of salivary gland (CASG): an international interobserver study
B Xu, AL Barbieri, JA Bishop, SI Chiosea, S Dogan, S Di Palma, ...
The American journal of surgical pathology 44 (4), 545-552, 2020
472020
Immunohistochemical analysis of IDH2 R172 hotspot mutations in breast papillary neoplasms: applications in the diagnosis of tall cell carcinoma with reverse polarity
F Pareja, EM da Silva, D Frosina, FC Geyer, JR Lozada, T Basili, ...
Modern Pathology 33 (6), 1056-1064, 2020
382020
Histologic spectrum of polymorphous adenocarcinoma of the salivary gland harbor genetic alterations affecting PRKD genes
APM Sebastiao, B Xu, JR Lozada, F Pareja, FC Geyer, ADC Paula, ...
Modern Pathology 33 (1), 65-73, 2020
342020
Myxoid fibroadenomas differ from conventional fibroadenomas: a hypothesis‐generating study
JR Lozada, KA Burke, A Maguire, F Pareja, RS Lim, J Kim, ...
Histopathology 71 (4), 626-634, 2017
312017
Massively parallel sequencing analysis of benign melanocytic naevi
JR Lozada, FC Geyer, P Selenica, D Brown, B Alemar, T Merghoub, ...
Histopathology 75 (1), 29-38, 2019
152019
ST3GAL1 and βII-spectrin pathways control CAR T cell migration to target tumors
Y Hong, BL Walling, HR Kim, WS Serratelli, JR Lozada, CJ Sailer, ...
Nature immunology 24 (6), 1007-1019, 2023
122023
Whole‐exome analysis of metaplastic breast carcinomas with extensive osseous differentiation
F Beca, APM Sebastiao, F Pareja, K Dessources, JR Lozada, F Geyer, ...
Histopathology 77 (2), 321-326, 2020
72020
Abstract PD4-13: Estrogen receptor-negative breast adenomyoepitheliomas are driven by co-occurring HRAS hotspot and PI3K pathway gene mutations: A genetic …
FC Geyer, A Li, AD Papanastasiou, A Smith, P Selenica, KA Burke, ...
Cancer Research 78 (4_Supplement), PD4-13-PD4-13, 2018
32018
Divergent immune microenvironments in two tumor nodules from a patient with mismatch repair-deficient prostate cancer
HE Bergom, LA Sena, A Day, B Miller, CD Miller, JR Lozada, N Zorko, ...
npj Genomic Medicine 9 (1), 7, 2024
12024
NK Cells from Human Cytomegalovirus–Seropositive Individuals Have a Distinct Metabolic Profile That Correlates with Elevated mTOR Signaling
JR Lozada, B Zhang, JS Miller, F Cichocki
The Journal of Immunology 211 (4), 539-550, 2023
12023
Metastatic Prostate Cancers with BRCA2 versus ATM Mutations Exhibit Divergent Molecular Features and Clinical Outcomes
J Hwang, X Shi, A Elliott, TE Arnoff, J McGrath, J Xiu, P Walker, ...
Clinical Cancer Research 29 (14), 2702-2713, 2023
12023
Pan-cancer analysis of natural killer (NK) cell infiltration in human malignancies: Molecular features and clinical implications.
N Zorko, J Hwang, JR Lozada, H Seifert, A Elliott, M Radovich, ...
Journal of Clinical Oncology 41 (16_suppl), 2563-2563, 2023
12023
ALAN is a computational approach that interprets genomic findings in the context of tumor ecosystems
HE Bergom, A Shabaneh, A Day, A Ali, E Boytim, S Tape, JR Lozada, ...
Communications biology 6 (1), 417, 2023
12023
Molecular correlates of Delta-like-ligand 3 (DLL3) expression in neuroendocrine neoplasms (NENs)
J Hwang, J McGrath, JR Lozada, P Brodskiy, J Xiu, S Wei, EI Heath, ...
J. Clin. Oncol 40, 4127, 2022
12022
Massively parallel sequencing analysis of myxoid fibroadenomas reveals a genomic landscape distinct from that of conventional fibroadenomas
JR Lozada, F Pareja, KA Burke, A Maguire, M Murray, E Brogi, B Weigelt, ...
LABORATORY INVESTIGATION 97, 57A-57A, 2017
12017
Natural Killer Cell Infiltration in Prostate Cancers Predict Improved Patient Outcomes
NA Zorko, A Makovec, A Elliott, S Kellen, JR Lozada, AT Arafa, M Felices, ...
Prostate Cancer and Prostatic Diseases, 1-9, 2024
2024
The system can't perform the operation now. Try again later.
Articles 1–20